Response to Hasan et aḷ., “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T-cell lymphoma: A retrospective cohort study”

YUNG-TSU CHOCHIA-YU CHU2024-11-072024-11-072024-01-0101909622https://scholars.lib.ntu.edu.tw/handle/123456789/722853enfalseFOXP3atopic dermatitiscutaneous T-cell lymphomadupilumabseverity[SDGs]SDG3Response to Hasan et aḷ., “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T-cell lymphoma: A retrospective cohort study”letter10.1016/j.jaad.2024.06.105391870142-s2.0-85204674656